Company intelligence / Profile preview

Maxpro Ventures

Ownership: Private
Development stage: Other

Overview

Maxpro Ventures is an active biomedical technology investment firm established in 2013. It focuses on identifying and investing in innovative drug, device, diagnostic, and healthcare service companies worldwide. The team has deep expertise across biotechnology and pharmaceuticals. They have made at least three known investments as of 2024.

Modalities: Cell therapyGene therapyBiologic drugsMedical devicesDiagnostics
Industry: Investors

Partnerships

CDIB Capital GroupNational Development Fund (Taiwan)TaiAn Technologies

Beyond the preview

Go deeper on Maxpro Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maxpro Ventures.

Explore the full profile